Glycemic targets in patients with diabetes.
10.5124/jkma.2017.60.11.889
- Author:
Ja Young JEON
1
;
Dae Jung KIM
Author Information
1. Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, Korea. djkim@ajou.ac.kr
- Publication Type:Original Article
- Keywords:
Diabetes mellitus;
Glycated hemoglobin A;
Standard care;
Diabetes complications
- MeSH:
Blood Glucose;
Comorbidity;
Diabetes Complications;
Diabetes Mellitus;
Humans;
Hyperglycemia;
Hypoglycemia;
Life Expectancy
- From:Journal of the Korean Medical Association
2017;60(11):889-892
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Diabetes is characterized by hyperglycemia, and chronic hyperglycemia leads to microvascular and macrovascular complications. Glycemic control is assessed and monitored by hemoglobin A1c and self-monitoring of blood glucose. Most guidelines recommend achieving hemoglobin A1c targets of <6.5% or 7%. Improved glycemic control reduces microvascular complications. However, intensive glycemic-control can have different effects on cardiovascular complications depending on the patient population. The glycemic targets should be individualized based on each patient's characteristics, such as age, duration of diabetes, accompanying comorbidities, risk of severe hypoglycemia, life expectancy, and attitude towards treatment.
